Analyst consensus rating
Dr. Reddy's Laboratories Analyst Rating: Buy
Direct answer
Dr. Reddy's Laboratories's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.31.
Forecast evidence checked October 31, 2026.
Get free Dr. Reddy's Laboratories email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.17
- Average price target
- $14.31
- High price target
- $15.70
- Low price target
- $12.50
- Low target gap
- -11.8%
- Target upside
- +1%
- High target gap
- +10.8%
- Target range width
- 22.6%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- October 31, 2026
- Valid through
- November 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories has a verified Buy consensus. The same dataset has an average price target of $14.31.
How far are Dr. Reddy's Laboratories's low and high targets from the recorded price?
The low target implies -11.8%, while the high target implies +10.8%.
How many analysts are included in Dr. Reddy's Laboratories's consensus?
The verified consensus includes 5 analysts.
How is Dr. Reddy's Laboratories's target upside or downside calculated?
The average target of $14.31 is divided by the recorded price of $14.17, then one is subtracted to produce +1%. This does not guarantee a future return.
When was Dr. Reddy's Laboratories's analyst forecast verified?
The data was verified on 2026-10-31. The dataset is valid through 2026-11-07.